Which is not used in status epilepticus?

Combined AIIMS - 2020 (Jodhpur, Bhopal, Patna, Raipur)

Pharmacology

Easy

Appeared in: Combined AIIMS - 2020 (Jodhpur, Bhopal, Patna, Raipur)

Explanation

Ethosuximide is a narrow-spectrum antiepileptic drug with a specific indication.
Its primary and almost exclusive use is for the treatment of absence (petit mal) seizures.
The mechanism involves suppressing T-type calcium currents in thalamic neurons, which is specific to the pathophysiology of absence seizures.
It is not effective against the generalized tonic-clonic activity characteristic of convulsive status epilepticus and is therefore not included in treatment guidelines for this condition.

Option A: Valproate (valproic acid) is a broad-spectrum antiepileptic drug available in an intravenous formulation. It is a recommended second-line agent for treating status epilepticus when first-line benzodiazepines are ineffective.
Option C: Fosphenytoin is a water-soluble prodrug of phenytoin. It is administered intravenously and is a standard, evidence-based second-line therapy for status epilepticus.
Option D: Levetiracetam is a broad-spectrum antiepileptic drug available for intravenous use. It is recommended as a second-line option for status epilepticus and is often favored due to its relatively benign side-effect profile and fewer drug interactions.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Pharmacotherapy for Status Epilepticus as background academic context rather than a clinical decision trigger.
Status epilepticus is a life-threatening neurological emergency. Rapid and appropriate treatment is crucial to prevent irreversible neuronal damage, systemic complications, and death.
The nurse plays a vital role in managing a patient with status epilepticus. Key responsibilities include securing IV access, administering medications promptly as ordered, continuous monitoring of vital signs (especially respiratory status and blood pressure), and observing for seizure cessation.
Nurses must be aware of the potential adverse effects of antiepileptic drugs, such as respiratory depression and hypotension with benzodiazepines and phenobarbital, or cardiac arrhythmias with fosphenytoin.

How to Approach the Question

Identify the core of the question: It asks which drug is NOT used for a specific condition (status epilepticus). This is a negative question, requiring elimination of the correct treatments.
Define the condition: Status epilepticus is a prolonged seizure emergency.
Recall the standard treatment protocol for status epilepticus. This typically involves staged therapy.
Step 1: First-line agents are benzodiazepines (e.g., lorazepam).
Step 2: Second-line agents are IV antiepileptics like fosphenytoin, valproate, and levetiracetam.
Evaluate each option against this protocol. Valproate, Fosphenytoin, and Levetiracetam are all established second-line treatments.

Concept Tested & Keywords

Concept Tested: Pharmacotherapy for Status Epilepticus
Stem keywords: status epilepticus, not used
Lead-in keywords: not
Negative lead-in flag: The question asks to identify the medication that is NOT part of the treatment protocol for status epilepticus.

Q4Gnw9uCrbZrW3HCixxwX-

E6 Pharmacology KD Tripathi Essentials 9e Part 2 p. 81-83

E6 Nelson Textbook of Pediatrics(2024) — Volume 2 p. 1434-1436